1.36
前日終値:
$1.35
開ける:
$1.35
24時間の取引高:
159.35K
Relative Volume:
0.28
時価総額:
$174.43M
収益:
$272.07M
当期純損益:
$-248.06M
株価収益率:
-0.6744
EPS:
-2.0167
ネットキャッシュフロー:
$-16.48M
1週間 パフォーマンス:
-2.16%
1か月 パフォーマンス:
-21.39%
6か月 パフォーマンス:
-25.27%
1年 パフォーマンス:
-21.39%
Waldencast Plc Stock (WALD) Company Profile
名前
Waldencast Plc
電話
(917) 546-6828
住所
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, CCL, KVUE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
WALD
Waldencast Plc
|
1.36 | 173.15M | 272.07M | -248.06M | -16.48M | -2.0167 |
|
PG
Procter Gamble Co
|
143.12 | 336.00B | 86.72B | 16.69B | 15.03B | 6.8375 |
|
UL
Unilever Plc Adr
|
61.23 | 133.70B | 56.67B | 6.96B | 7.39B | 3.1265 |
|
CL
Colgate Palmolive Co
|
90.21 | 73.30B | 20.80B | 2.22B | 3.77B | 2.5772 |
|
CCL
Colgate Palmolive Co
|
27.73 | 38.51B | 26.98B | 3.10B | 2.98B | 2.2492 |
|
KVUE
Kenvue Inc
|
18.79 | 36.88B | 15.29B | 1.62B | 1.82B | 0.8433 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-14 | 再開されました | Jefferies | Buy |
| 2025-11-25 | ダウングレード | Telsey Advisory Group | Outperform → Market Perform |
| 2025-04-22 | 開始されました | Alliance Global Partners | Buy |
| 2024-12-16 | 開始されました | TD Cowen | Hold |
| 2024-10-25 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-01 | 繰り返されました | Telsey Advisory Group | Outperform |
| 2023-07-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
すべてを表示
Waldencast Plc (WALD) 最新ニュース
Waldencast PLC (NASDAQ:WALD) Short Interest Up 121.7% in July - MarketBeat
Waldencast (WALD) Surges 7.8% to $1.38, Pressuring Resistance at $1.45Call Spread Alert - dars.gov.et
Waldencast plc (WALD) repurchases 193,816 RSUs as Hind Sebti moves to Obagi - Stock Titan
Waldencast PLC (WALD) Stock News Today - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Waldencast plc (WAL - The National Law Review
Waldencast PLC (WALD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority - TipRanks
Waldencast (WALD) investors approve directors, auditor and share repurchase - Stock Titan
Waldencast (WALD) Edges Higher: Beauty Stock Approaches Key Resistance at $1.82Merger Arbitrage - dars.gov.et
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast (NASDAQ: WALD) completes Obagi sale valued up to $460M - Stock Titan
Waldencast plc Revenue Breakdown – NASDAQ:WALD - TradingView
Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt - tipranks.com
Waldencast Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Waldencast PLC (WALD) Balance Sheet - TradingKey
Waldencast Hits Indicted Obagi Ex-CEO With 9-Figure Fraud Case - Bloomberg Law News
Waldencast PLC (WALD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Cash Flow - TradingKey
Waldencast PLC (WALD) Income Statement - TradingKey
Waldencast PLC (WALD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
WALD|Waldencast PLC|Price:1.720|Chg%:+0.030 - TradingKey
WALD|Waldencast PLC|Price:1.690| - TradingKey
WALD|Waldencast PLC|Price:1.730|Chg%:+0.040 - TradingKey
Waldencast (WALD) Q4 2024 earnings summary - Quartr
Waldencast Company Profile & Introduction - Moomoo
Waldencast PLC (WALD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WALD Q4 2024 Earnings: Significant EPS Miss Raises ConcernsEarnings Revision Downgrade - dars.gov.et
WALD|Waldencast PLC|Price:1.675|Chg%:-0.045 - TradingKey
Waldencast plc (WALD) Q4 2024 Earnings: EPS Misses Estimates by a Wide Margin, Yet Shares RiseEPS Revision Trend - dars.gov.et
Waldencast Q4 2024 Earnings: EPS Misses Estimates as Stock Rises Despite Wide LossEPS Guidance Update - dars.gov.et
WALD Q4 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesAnalyst Earnings Estimate - dars.gov.et
Price to sales forward of Waldencast plc – NASDAQ:WALD - TradingView
Price to book forward of Waldencast plc – NASDAQ:WALD - TradingView
Enterprise value to EBIT forward of Waldencast plc – NASDAQ:WALD - TradingView
Price to earnings forward of Waldencast plc – NASDAQ:WALD - TradingView
Waldencast (WALD) Slips 1.17% as Stock Hovers Near Key Support LevelChandelier Stop - dars.gov.et
Discover TROOPS And 2 Other Promising Penny Stocks - Sahm
Waldencast (WALD) Q4 2024 Earnings: EPS Misses Estimates as Revenue Details Remain Undisclosed - dars.gov.et
Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus - TipRanks
[6-K] Waldencast plc Current Report (Foreign Issuer) | WALD SEC FilingForm 6-K - Stock Titan
Short Interest in Waldencast PLC (NASDAQ:WALD) Drops By 84.6% - MarketBeat
Waldencast Q4 2024 Earnings: Significant EPS Miss Amidst Strategic ChallengesBuyback Announcement Report - dars.gov.et
Waldencast (WALD) Edges Higher Amid Consolidation Near Key SupportLiquidity Order Flow - dars.gov.et
WALD Q4 2024 Earnings: EPS Misses by Wide Margin, Stock DeclinesPost-Announcement Reaction - dars.gov.et
Waldencast plc (WALD) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
Waldencast plc Warrant Financial Disclosures & SEC Filings - TradingView
Waldencast plc Q4 2024 Earnings: Wide Earnings Miss Sends Stock LowerROIC Trend Report - dars.gov.et
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - NTB Kommunikasjon
WALD Stock Price and Chart — NASDAQ:WALD - TradingView
Price to earnings forward of Waldencast plc – NASDAQ:WALDW - TradingView
Waldencast Plc (WALD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):